DURHAM, N.C., November 15, 2012 -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results